Home » Newsletters » BioWorld

BioWorld

June 4, 1993

View Archived Issues

FDA SETS UP NEW SYSTEM TO REPORT ADVERSE REACTIONS

APPOINTMENTS AND ADVANCEMENTS

PACT WITH MMD WORTH $17.5M TO SEPRACOR

UNIVAX FILES PLA

PROCORDIA TO FOCUS ON BIOTECH

THREE-WAY PCR DISPUTE RESOLVED

GERON RAISES $10.7M IN VENTURE FINANCING

BAXTER DISTRIBUTES STEM-CELL SELECTION SYSTEM

RHONE BUYS 37% OF AIS FOR $113M

CENTORX ENTERS PHASE III FOR ANGINA

$20 MILLION ALPHA-BETA PRIVATE PLACEMENT

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...